Sastasundar Ventures Limited, incorporated in 1989, is a Core Investment Company (CIC) that operates through multiple subsidiaries. It offers a digital platform for pharmacy, wellness, and diagnostics, serving both B2B and B2C segments with person-centric healthcare solutions. The company was formerly known as Microsec Financial Services Limited and changed its name to Sastasundar Ventures Limited in November 2016.
The company operates as a comprehensive digital healthcare ecosystem, bridging the gap between traditional healthcare services and modern technology-driven solutions. Through its subsidiaries, it operates a digital network of healthcare and portfolio management services in India, functioning through Financial Services and Healthcare Network segments. At present, the company is largely focusing on the business of digital network of healthcare and portfolio management services.
The company provides Digital Platforms for Pharmacy, Wellness & Diagnostics, offering Accessible, Affordable, Scalable & Sustainable Person-Centric Healthcare Solutions. This is achieved through a consumer-focused digital healthcare platform consisting of pharmacy, diagnostics, and wellness services. The company operates `www.sastasundar.com` and `www.retailershakti.com` portals for pathology and healthcare products marketing activities, as well as providing diagnostic services, such as pathological/radiological investigations.
In 2014, Sastasundar.com, an innovative digital pharmacy and healthcare store, was launched. Currently, they have a network of 239 branches, of which 99 are located in Kolkata. During FY22, for RetailerShakti (B2B digital healthcare platform), GMV grew by close to 55%, and GENU Path Labs (diagnostic vertical) revenue grew by 89%.
Beyond healthcare, Sastasundar Ventures maintains significant financial services operations. The company engages in financing of loans and invests in shares and securities, as well as providing financial consultancy, professional fees, wealth management, financial planning, distribution, and related services. The company also gives loans against shares to its clients at appropriate margin levels.
The company has a market capitalization of ₹986 crore. For the year ended 2024, Sastasundar Ventures Ltd posted a profit of ₹5.85 crore on a total income of ₹1,432.04 crore. On a consolidated basis, Sastasundar Ventures Ltd reported a profit of ₹13.39 crore on a total income of ₹307.75 crore for the quarter ended 2025.
- Net Profit Q4 2024-2025: ₹13.67 crore (decline of 16.85% YoY)
- Quarterly Net Profit Growth: 150.74% (since last 3 months)
- Median Sales Growth (last 10 years): 37.1%
- Working Capital Reduction: From 63.1 days to 38.7 days
- Market Capitalization: ₹986 crore
- Promoter Holding: 74.11% (as of March 2025)
During FY22, Flipkart acquired a majority share in Sastasundar Marketplace Limited, which owns and operates SastaSundar.com, marking Flipkart's foray into the healthcare space. The company is backed by globally acclaimed investors including Mitsubishi Corporation Japan and Rohto Pharmaceutical company Ltd.
The Chairman and Managing Director of the company is Banwari Lal Mittal. The founders of Sastasundar Ventures are Ravi Kant Sharma and B L Mittal, with Ravi Kant Sharma serving as the CEO.
Sastasundar Ventures has significantly reduced debt and is almost debt-free. This strengthens its balance sheet, enabling it to report stable earnings growth across business cycles. However, the company has a low interest coverage ratio and a low return on equity of -1.12% over the last 3 years.
Promoter holding in Sastasundar Ventures Ltd increased to 74.11% as of March 2025 from 73.92% as of June 2024. There is no promoter pledging in Sastasundar Ventures Ltd.
The company has demonstrated strong growth momentum in its healthcare vertical. It has compounded sales growth by 65% CAGR over the past 5 years and almost 96% over the past 3 years. The company is in further talks to raise money to go national, indicating strong investor confidence despite the tough competition in the E-pharmacy space. The offline-to-online model can be a significant disruptor in the healthcare sector.
Sastasundar Ventures represents a unique investment opportunity in India's rapidly growing digital healthcare sector, combining traditional financial services with innovative healthcare technology platforms. The company's debt-free status, strong promoter holding, and strategic partnerships position it well for future growth in the expanding e-pharmacy and digital health services market.
